Shandong Xinhua Pharmaceutical Company Limited (0719.HK)
HKD 5.78
(0.0%)
HKD 5.78
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 534.58 Million CNY | 12.14% |
| 2022 | 476.7 Million CNY | 12.01% |
| 2021 | 425.59 Million CNY | 0.73% |
| 2020 | 422.48 Million CNY | 9.05% |
| 2019 | 387.43 Million CNY | 14.86% |
| 2018 | 337.31 Million CNY | 19.75% |
| 2017 | 281.68 Million CNY | 91.4% |
| 2016 | 147.16 Million CNY | 59.85% |
| 2015 | 92.06 Million CNY | 68.75% |
| 2014 | 54.55 Million CNY | 224.39% |
| 2013 | -43.86 Million CNY | -134.49% |
| 2012 | -18.7 Million CNY | -126.01% |
| 2011 | 71.92 Million CNY | -45.39% |
| 2010 | 131.7 Million CNY | -3.1% |
| 2009 | 135.9 Million CNY | 273.46% |
| 2008 | 36.39 Million CNY | 2.65% |
| 2007 | 35.45 Million CNY | 26.05% |
| 2006 | 28.12 Million CNY | 1436.0% |
| 2005 | -2.1 Million CNY | 95.93% |
| 2004 | -51.72 Million CNY | -199.43% |
| 2003 | 52.01 Million CNY | -39.42% |
| 2002 | 85.86 Million CNY | -15.53% |
| 2001 | 101.64 Million CNY | 16.7% |
| 2000 | 87.1 Million CNY | 13.17% |
| 1999 | 76.96 Million CNY | 9.83% |
| 1998 | 70.07 Million CNY | -29.06% |
| 1997 | 98.78 Million CNY | -0.46% |
| 1996 | 99.24 Million CNY | 148.31% |
| 1995 | 39.96 Million CNY | -37.81% |
| 1994 | 64.27 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 90.7 Million CNY | -33.8% |
| 2024 Q1 | 170.55 Million CNY | 94.45% |
| 2024 Q2 | 137.01 Million CNY | -19.67% |
| 2023 Q4 | 87.71 Million CNY | -22.32% |
| 2023 Q2 | 148.15 Million CNY | -20.26% |
| 2023 FY | 534.58 Million CNY | 12.14% |
| 2023 Q3 | 112.91 Million CNY | -23.79% |
| 2023 Q1 | 185.79 Million CNY | 34.03% |
| 2022 Q1 | 133.71 Million CNY | 64.3% |
| 2022 Q4 | 138.62 Million CNY | 38.19% |
| 2022 Q3 | 100.31 Million CNY | -3.59% |
| 2022 FY | 476.7 Million CNY | 12.01% |
| 2022 Q2 | 104.05 Million CNY | -22.18% |
| 2021 Q3 | 81.01 Million CNY | -38.96% |
| 2021 Q1 | 130.46 Million CNY | 50.2% |
| 2021 Q2 | 132.72 Million CNY | 1.74% |
| 2021 Q4 | 81.38 Million CNY | 0.45% |
| 2021 FY | 425.59 Million CNY | 0.73% |
| 2020 Q4 | 86.85 Million CNY | -15.6% |
| 2020 Q1 | 116.12 Million CNY | 57.58% |
| 2020 FY | 422.48 Million CNY | 9.05% |
| 2020 Q3 | 102.9 Million CNY | -11.74% |
| 2020 Q2 | 116.59 Million CNY | 0.41% |
| 2019 Q2 | 99.08 Million CNY | -1.28% |
| 2019 FY | 387.43 Million CNY | 14.86% |
| 2019 Q1 | 100.37 Million CNY | 32.47% |
| 2019 Q3 | 114.28 Million CNY | 15.35% |
| 2019 Q4 | 73.69 Million CNY | -35.52% |
| 2018 Q2 | 82.71 Million CNY | -0.84% |
| 2018 Q3 | 95.41 Million CNY | 15.35% |
| 2018 FY | 337.31 Million CNY | 19.75% |
| 2018 Q1 | 83.41 Million CNY | -19.6% |
| 2018 Q4 | 75.76 Million CNY | -20.59% |
| 2017 Q3 | 48.02 Million CNY | -32.75% |
| 2017 Q1 | 58.49 Million CNY | 134.17% |
| 2017 Q2 | 71.41 Million CNY | 22.08% |
| 2017 FY | 281.68 Million CNY | 91.4% |
| 2017 Q4 | 103.74 Million CNY | 116.02% |
| 2016 FY | 147.16 Million CNY | 59.85% |
| 2016 Q3 | 53.53 Million CNY | 45.61% |
| 2016 Q2 | 36.76 Million CNY | 15.32% |
| 2016 Q1 | 31.88 Million CNY | 654.44% |
| 2016 Q4 | 24.98 Million CNY | -53.34% |
| 2015 FY | 92.06 Million CNY | 68.75% |
| 2015 Q1 | 19.41 Million CNY | 12.75% |
| 2015 Q4 | 4.22 Million CNY | -91.12% |
| 2015 Q3 | 47.58 Million CNY | 128.29% |
| 2015 Q2 | 20.84 Million CNY | 7.38% |
| 2014 Q3 | 13.77 Million CNY | -11.48% |
| 2014 Q4 | 17.21 Million CNY | 25.02% |
| 2014 FY | 54.55 Million CNY | 224.39% |
| 2014 Q1 | 8.01 Million CNY | 132.82% |
| 2014 Q2 | 15.55 Million CNY | 94.19% |
| 2013 Q1 | -9.74 Million CNY | 77.64% |
| 2013 Q3 | -6.4 Million CNY | -94.1% |
| 2013 FY | -43.86 Million CNY | -134.49% |
| 2013 Q4 | -24.41 Million CNY | -281.29% |
| 2013 Q2 | -3.29 Million CNY | 66.16% |
| 2012 Q3 | -634.18 Thousand CNY | -113.8% |
| 2012 Q2 | 4.59 Million CNY | -78.03% |
| 2012 FY | -18.7 Million CNY | -126.01% |
| 2012 Q1 | 20.92 Million CNY | 164.41% |
| 2012 Q4 | -43.59 Million CNY | -6774.25% |
| 2011 Q4 | -32.49 Million CNY | -230.37% |
| 2011 Q1 | 38.24 Million CNY | 68.0% |
| 2011 Q2 | 41.25 Million CNY | 7.85% |
| 2011 Q3 | 24.92 Million CNY | -39.58% |
| 2011 FY | 71.92 Million CNY | -45.39% |
| 2010 Q3 | 37.79 Million CNY | 9.35% |
| 2010 FY | 131.7 Million CNY | -3.1% |
| 2010 Q1 | 36.57 Million CNY | -22.83% |
| 2010 Q2 | 34.56 Million CNY | -5.51% |
| 2010 Q4 | 22.76 Million CNY | -39.77% |
| 2009 Q3 | 30.46 Million CNY | -3.23% |
| 2009 Q2 | 31.48 Million CNY | 18.57% |
| 2009 FY | 135.9 Million CNY | 273.46% |
| 2009 Q1 | 26.55 Million CNY | 162.9% |
| 2009 Q4 | 47.4 Million CNY | 55.57% |
| 2008 FY | 36.39 Million CNY | 2.65% |
| 2008 Q4 | 10.1 Million CNY | 292.86% |
| 2008 Q3 | -5.23 Million CNY | -137.21% |
| 2008 Q2 | 14.07 Million CNY | -19.37% |
| 2008 Q1 | 17.45 Million CNY | 2024.38% |
| 2007 Q2 | 12.19 Million CNY | -11.84% |
| 2007 Q1 | 13.83 Million CNY | 110.69% |
| 2007 FY | 35.45 Million CNY | 26.05% |
| 2007 Q4 | -907.04 Thousand CNY | -108.78% |
| 2007 Q3 | 10.33 Million CNY | -15.3% |
| 2006 Q4 | 6.56 Million CNY | 31.72% |
| 2006 Q3 | 4.98 Million CNY | 12.41% |
| 2006 Q2 | 4.43 Million CNY | -63.48% |
| 2006 FY | 28.12 Million CNY | 1436.0% |
| 2006 Q1 | 12.14 Million CNY | 148.76% |
| 2005 Q2 | 7.75 Million CNY | -34.42% |
| 2005 Q4 | -24.89 Million CNY | -874.75% |
| 2005 Q3 | 3.21 Million CNY | -58.56% |
| 2005 FY | -2.1 Million CNY | 95.93% |
| 2005 Q1 | 11.82 Million CNY | 113.71% |
| 2004 Q3 | -561.26 Thousand CNY | -103.85% |
| 2004 Q1 | 20.48 Million CNY | 420.06% |
| 2004 FY | -51.72 Million CNY | -199.43% |
| 2004 Q2 | 14.57 Million CNY | -28.84% |
| 2004 Q4 | -86.22 Million CNY | -15262.38% |
| 2003 FY | 52.01 Million CNY | -39.42% |
| 2003 Q3 | 6.02 Million CNY | -73.85% |
| 2003 Q2 | 23.05 Million CNY | -21.4% |
| 2003 Q1 | 29.33 Million CNY | 85.05% |
| 2003 Q4 | -6.4 Million CNY | -206.16% |
| 2002 Q2 | 21.18 Million CNY | -26.89% |
| 2002 Q1 | 28.98 Million CNY | 0.0% |
| 2002 Q3 | 19.84 Million CNY | -6.36% |
| 2002 Q4 | 15.85 Million CNY | -20.11% |
| 2002 FY | 85.86 Million CNY | -15.53% |
| 2001 FY | 101.64 Million CNY | 16.7% |
| 2000 FY | 87.1 Million CNY | 13.17% |
| 1999 FY | 76.96 Million CNY | 9.83% |
| 1998 FY | 70.07 Million CNY | -29.06% |
| 1997 FY | 98.78 Million CNY | -0.46% |
| 1996 FY | 99.24 Million CNY | 148.31% |
| 1995 FY | 39.96 Million CNY | -37.81% |
| 1994 FY | 64.27 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 143.01 Million HKD | -273.802% |
| Grand Pharmaceutical Group Limited | 2.66 Billion HKD | 79.929% |
| Extrawell Pharmaceutical Holdings Limited | -8.16 Million HKD | 6649.645% |
| Wai Yuen Tong Medicine Holdings Limited | 40.88 Million HKD | -1207.686% |
| Qianhai Health Holdings Limited | -52.18 Million HKD | 1124.437% |
| Lee's Pharmaceutical Holdings Limited | 36.04 Million HKD | -1383.22% |
| Essex Bio-Technology Limited | 310.32 Million HKD | -72.263% |
| Tongfang Kontafarma Holdings Limited | - HKD | -Infinity% |
| PuraPharm Corporation Limited | -66.04 Million HKD | 909.409% |
| SSY Group Limited | 1.63 Billion HKD | 67.382% |
| JBM (Healthcare) Limited | 174.2 Million HKD | -206.869% |
| Jacobson Pharma Corporation Limited | 333.12 Million HKD | -60.474% |
| China Resources Pharmaceutical Group Limited | 12.14 Billion HKD | 95.599% |